
A synthetic Thymosin β4 fragment studied for actin regulation and repair research.
Secure checkout · Free AU express over $99 · Research use only
TB-500 is a synthetic version of an active region of Thymosin β4, a naturally occurring actin-binding peptide. Research investigates its influence on cell migration, angiogenesis and tissue-repair pathways in experimental models.
In controlled laboratory environments, TB-500 is studied for:
The C-terminal α-MSH tripeptide studied for anti-inflammatory pathway research.
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Join the Pepreta research list for new product drops, third-party COA releases and members-only pricing. No spam — unsubscribe anytime.